IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 49.86

Change

+0.74 (+1.51)%

Market Cap

N/A

Volume

0.13M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-23 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+0.67 (+0.50%)

USD 35.08B
FHLC Fidelity® MSCI Health Care In..

+0.40 (+0.63%)

USD 2.50B
FXH First Trust Health Care AlphaD..

+1.17 (+1.22%)

USD 0.89B
XHE SPDR® S&P Health Care Equipme..

+1.58 (+2.09%)

USD 0.16B
IDNA iShares Genomics Immunology an..

+0.27 (+1.35%)

USD 0.10B
XHS SPDR® S&P Health Care Service..

+1.73 (+1.88%)

USD 0.09B
SBIO ALPS Medical Breakthroughs ETF

+0.45 (+1.63%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.60 (+2.35%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

+0.88 (+1.60%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.36 (+2.01%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 10.15 % 0.00 %

+0.45 (+1.78%)

USD 0.10B
LCR Managed Portfolio Series 0.00 % 0.00 %

+0.16 (+1.78%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.90% 95% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.90% 95% A 83% B
Trailing 12 Months  
Capital Gain -4.57% 33% F 36% F
Dividend Return 0.59% 56% F 9% A-
Total Return -3.99% 33% F 29% F
Trailing 5 Years  
Capital Gain 32.05% 81% B- 49% F
Dividend Return 5.36% 63% D 10% F
Total Return 37.41% 71% C- 39% F
Average Annual (5 Year Horizon)  
Capital Gain 3.19% 67% D+ 48% F
Dividend Return 3.84% 62% D 42% F
Total Return 0.65% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.79% 43% F 52% F
Risk Adjusted Return 19.40% 57% F 37% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.